Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,686,278,442
+$3,816,650,575 QoQ
Shares Held
13,911,839
-0.6% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
1.69%
of 13F equity value
Holder Rank
#12
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $40,270,584,407 across 16 Drug Manufacturers - General names. LLY ranks #1 (41.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
13,911,839 | $16,686,278,442 | |
| 2 | JNJ |
Johnson & Johnson
|
22,996,878 | $5,840,517,105 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,996,694 | $3,789,782,319 | |
| 4 | ABBV |
AbbVie Inc.
|
14,749,069 | $3,711,455,722 | |
| 5 | AZN |
Astrazeneca PLC
|
16,616,629 | $3,150,845,190 | |
| 6 | MRK |
Merck & Co., Inc.
|
18,518,796 | $2,379,665,285 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,707,643 | $1,826,994,388 | |
| 8 | AMGN |
Amgen Inc
|
3,956,992 | $1,432,905,943 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,686,278,442 | 13,911,839 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,869,627,867 | 13,992,224 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,024,023,003 | 14,910,505 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,284,046,668 | 13,478,436 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,131,264,700 | 16,845,105 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,802,370,588 | 19,133,284 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $16,106,983,296 | 20,863,968 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,542,978,464 | 20,930,287 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $18,697,668,739 | 20,651,736 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,036,136,935 | 20,613,061 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $12,723,147,098 | 21,826,575 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $11,943,618,381 | 22,235,992 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $11,331,006,550 | 24,160,959 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,803,441,310 | 22,722,734 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,293,223,300 | 22,668,990 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,031,794,768 | 24,839,322 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,622,935,323 | 20,426,658 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,992,225,525 | 20,924,767 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,956,450,988 | 25,184,458 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,990,667,515 | 30,256,081 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,137,184,856 | 26,739,216 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,886,277,286 | 26,155,001 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,042,054,458 | 12,094,613 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,185,919,217 | 8,011,885 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,043,399,691 | 6,355,218 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $595,468,778 | 4,292,595 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||